Most cited papers from Cubist Pharmaceuticals (United States)
What are the most cited papers from Cubist Pharmaceuticals (United States)?
The most cited paper from Cubist Pharmaceuticals (United States) is "Biofilms: the matrix revisited" (Steven S. Branda, Åshild Vik, Lisa Friedman et al., 2004), with 1,821 citations. Next come "Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus" (1,472) and "Tackling antibiotic resistance" (1,077).
Showing 50 of 60 papers. Every paper with more than 163 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Biofilms: the matrix revisited Steven S. Branda, Åshild Vik, Lisa Friedman et al. · Trends in Microbiology | 10 Dec 2004 | 1,821 |
| 2 | Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus Vance G. Fowler et al. · New England Journal of Medicine | 16 Aug 2006 | 1,472 |
| 3 | Tackling antibiotic resistance Karen Bush et al. · Nature Reviews Microbiology | 2 Nov 2011 | 1,077 |
| 4 | The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections Robert D. Arbeit, Dennis G. Maki, Frank Tally et al. · Clinical Infectious Diseases | 2 Jun 2004 | 697 |
| 5 | Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus Jared A. Silverman, Nancy G. Perlmutter, Howard M. Shapiro · Antimicrobial Agents and Chemotherapy | 23 Jul 2003 | 662 |
| 6 | Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections Judith N. Steenbergen, Jeff D. Alder, Grace M. Thorne et al. · Journal of Antimicrobial Chemotherapy | 10 Feb 2005 | 568 |
| 7 | Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact Jared A. Silverman, Lawrence I. Mortin, Andrew D. G. VanPraagh et al. · The Journal of Infectious Diseases | 20 May 2005 | 543 |
| 8 | Renaissance in antibacterial discovery from actinomycetes Richard H. Baltz · Current Opinion in Pharmacology | 4 Jun 2008 | 506 |
| 9 | Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes Mark C. Sulavik, Chad Houseweart, Christina Cramer et al. · Antimicrobial Agents and Chemotherapy | Apr 2001 | 503 |
| 10 | Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients* Yahya Shehabi, Richard R. Riker, Paula M. Bokesch et al. · Critical Care Medicine | 10 Sep 2010 | 477 |
| 11 | Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus Lisa Friedman, Jeff D. Alder, Jared A. Silverman · Antimicrobial Agents and Chemotherapy | 24 May 2006 | 457 |
| 12 | Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05 Gregory E. Steinkraus, Roger L. White, Lawrence V. Friedrich · Journal of Antimicrobial Chemotherapy | 10 Jul 2007 | 424 |
| 13 | Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI) Joseph S. Solomkin, Ellie Hershberger, Benjamin W. Miller et al. · Clinical Infectious Diseases | 10 Feb 2015 | 419 |
| 14 | The value of natural products to future pharmaceutical discovery Dwight D. Baker, Min Chu, Uma Oza et al. · Natural Product Reports | 2007 | 417 |
| 15 | Natural products to drugs: daptomycin and related lipopeptide antibiotics Richard H. Baltz, Vivian Miao, Stephen K. Wrigley · Natural Product Reports | 2005 | 398 |
| 16 | Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI) Florian Wagenlehner, Obiamiwe Umeh, Judith N. Steenbergen et al. · The Lancet | 28 Apr 2015 | 387 |
| 17 | Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry Vivian Miao, Marie-Françoise Coëffet-LeGal, Paul Brian et al. · Microbiology | May 2005 | 369 |
| 18 | Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects Barry H. Dvorchik, D J Brazier, Michael F. DeBruin et al. · Antimicrobial Agents and Chemotherapy | 24 Mar 2003 | 361 |
| 19 | Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis Dilip Nathwani, Gowri Raman, Katherine A. Sulham et al. · Antimicrobial Resistance and Infection Control | 20 Oct 2014 | 353 |
| 20 | Effects of control interventions on Clostridium difficile infection in England: an observational study Kate E. Dingle et al. · The Lancet Infectious Diseases | 24 Jan 2017 | 330 |
| 21 | Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins Joe Pogliano, N. Pogliano, Jared A. Silverman · Journal of Bacteriology | Jun 2012 | 326 |
| 22 | Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers Mark S. Benvenuto, David P. Benziger, Sara Yankelev et al. · Antimicrobial Agents and Chemotherapy | 27 Sep 2006 | 325 |
| 23 | Development of daptomycin for Gram-positive infections Francis P. Tally, Michael F. DeBruin · Journal of Antimicrobial Chemotherapy | Oct 2000 | 322 |
| 24 | Selective Postoperative Inhibition of Gastrointestinal Opioid Receptors Akiko Taguchi, Neeru Sharma, Rao M. Saleem et al. · New England Journal of Medicine | 27 Sep 2001 | 321 |
| 25 | Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases | 5 Jun 2014 | 309 |
| 26 | Revised guides for organ sampling and trimming in rats and mice – Part 1 Christine Ruehl-Fehlert, Birgit Kittel, Gerd Morawietz et al. · Experimental and Toxicologic Pathology | 2003 | 306 |
| 27 | Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist Bruce G. Wolff, Fabrizio Michelassi, Todd M. Gerkin et al. · Annals of Surgery | 21 Sep 2004 | 301 |
| 28 | Combinatorial biosynthesis of novel antibiotics related to daptomycin Kien Trung Nguyen, Daniel Ritz, Jian-Qiao Gu et al. · Proceedings of the National Academy of Sciences | 7 Nov 2006 | 291 |
| 29 | Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002 Aisha Obad Jumaan, Onchee Yu, Lisa A. Jackson et al. · The Journal of Infectious Diseases | 20 May 2005 | 286 |
| 30 | Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells Carmela T. M. Mascio, Jeff D. Alder, Jared A. Silverman · Antimicrobial Agents and Chemotherapy | 9 Oct 2007 | 279 |
| 31 | An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance Scott T. Micek, Richard G. Wunderink, Marin H. Kollef et al. · Critical Care | 30 Apr 2015 | 277 |
| 32 | Daptomycin: mechanisms of action and resistance, and biosynthetic engineering Richard H. Baltz · Current Opinion in Chemical Biology | 20 Mar 2009 | 268 |
| 33 | Structural Basis for Double-Sieve Discrimination of L-Valine from L-Isoleucine and L-Threonine by the Complex of tRNAVal and Valyl-tRNA Synthetase Shuya Fukai, Osamu Nureki, Shun‐ichi Sekine et al. · Cell | Nov 2000 | 268 |
| 34 | Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin George Sakoulas, Jeff D. Alder, Claudie Thauvin-Eliopoulos et al. · Antimicrobial Agents and Chemotherapy | 28 Mar 2006 | 263 |
| 35 | Comprehensive Survey of Combinatorial Library Synthesis: 2000 Roland E. Dolle · Journal of Combinatorial Chemistry | 6 Oct 2001 | 257 |
| 36 | Epidemiology of Clostridium difficile Infection Daryl D. DePestel, David Michael Aronoff · Journal of Pharmacy Practice | 24 Sep 2013 | 252 |
| 37 | Comprehensive Survey of Combinatorial Library Synthesis: 2005 Roland E. Dolle, Bertrand Le Bourdonnec, Guillermo A. Morales et al. · Journal of Combinatorial Chemistry | 23 Aug 2006 | 250 |
| 38 | Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? Richard H. Baltz · Journal of Industrial Microbiology & Biotechnology | 17 Jan 2006 | 248 |
| 39 | Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus Anton Yariv Peleg, Spiros Miyakis, Doyle V. Ward et al. · PLoS ONE | 6 Jan 2012 | 245 |
| 40 | Resistance Studies with Daptomycin Jared A. Silverman, N. Oliver, Ted Andrew et al. · Antimicrobial Agents and Chemotherapy | Jun 2001 | 235 |
| 41 | Drug discovery from natural products Vincent P. Gullo, James B. McAlpine, Kin S. Lam et al. · Journal of Industrial Microbiology & Biotechnology | 16 Mar 2006 | 224 |
| 42 | Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus Nagendra Nath Mishra, Soo‐Jin Yang, Ayumi Sawa et al. · Antimicrobial Agents and Chemotherapy | 31 Mar 2009 | 223 |
| 43 | Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery Conor Patrick Delaney, James Leighton Weese, Neil Hyman et al. · Diseases of the Colon & Rectum | 19 May 2005 | 220 |
| 44 | Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats Wayne B. Rowe, Eric M. Blalock, Kuey-Chu Chen et al. · Journal of Neuroscience | 21 Mar 2007 | 218 |
| 45 | Retrohoming of a Bacterial Group II Intron Benoit Cousineau, Dorie Smith, Stacey Lawrence-Cavanagh et al. · Cell | Aug 1998 | 218 |
| 46 | The Importance of Bactericidal Drugs: Future Directions in Infectious Disease Robert W. Finberg, Robert C. Moellering, Francis P. Tally et al. · Clinical Infectious Diseases | 15 Oct 2004 | 216 |
| 47 | Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat et al. · European Urology | 26 Feb 2014 | 215 |
| 48 | Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization Arunachalam Muthaiyan, Jared A. Silverman, Radheshyam K. Jayaswal et al. · Antimicrobial Agents and Chemotherapy | 17 Dec 2007 | 208 |
| 49 | Daptomycin: a novel agent for Gram-positive infections Francis P. Tally, Michael L. Zeckel, Margaret M. Wasilewski et al. · Expert Opinion on Investigational Drugs | Aug 1999 | 207 |
| 50 | Genetic Basis for Daptomycin Resistance in Enterococci Kelli L. Palmer, Anu Daniel, Crystal Hardy et al. · Antimicrobial Agents and Chemotherapy | 19 Apr 2011 | 200 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.